helpline 01494 601 400
Published: 04 April 2013

New epilepsy drug Fycompa (perampanel) launches

Pharmaceutical company Eisai, have launched a new anti-epileptic drug. Fycompa® (perampanel) is now available in the UK as an add-on (adjunctive) treatment of focal-onset (partial-onset) seizures, with or without secondarily generalisation, in people with epilepsy aged 12 years and older. Fycompa® is available as once-daily tablets in 2mg, 4mg, 6mg, 8mg, 10mg and 12mg tablets.